Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0043320230460010001
Archives of Pharmacal Research
2023 Volume.46 No. 1 p.1 ~ p.17
The role and application of transcriptional repressors in cancer treatment
Park Mi-So

Kang Keon-Wook
Kim Ji-Won
Abstract
Gene expression is modulated through the integration of many regulatory elements and their associated transcription factors (TFs). TFs bind to specific DNA sequences and either activate or repress transcriptional activity. Through decades of research, it has been established that aberrant expression or functional abnormalities of TFs can lead to uncontrolled cell division and the development of cancer. Initial studies on transcriptional regulation in cancer have focused on TFs as transcriptional activators. However, recent studies have demonstrated several different mechanisms of transcriptional repression in cancer, which could be potential therapeutic targets for the development of specific anti-cancer agents. In the first section of this review, ¡°Emerging roles of transcriptional repressors in cancer development,¡± we summarize the current understanding of transcriptional repressors and their involvement in the molecular processes of cancer progression. In the subsequent section, ¡°Therapeutic applications,¡± we provide an updated overview of the available therapeutic targets for drug discovery and discuss the new frontier of such applications.
KEYWORD
Transcriptional repressors, Cancer, Transcription factors, Gene expression
FullTexts / Linksout information
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI)